Skip to main content
Sansure Biotech Inc. logo

Sansure Biotech Inc. — Investor Relations & Filings

Ticker · 688289 ISIN · CNE1000043J1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 870 across all filing types
Latest filing 2026-04-15 AGM Information
Country CN China
Listing Shanghai Stock Exchange 688289

About Sansure Biotech Inc.

https://www.sansureglobal.com/

Sansure Biotech Inc. specializes in the development and manufacture of molecular diagnostic products and genetic testing solutions. The company utilizes proprietary technologies, such as the "One-tube" fast extraction method and advanced magnetic bead technology, to provide high-sensitivity PCR diagnostic kits. Its product portfolio covers a wide range of clinical applications, including infectious disease screening for hepatitis, respiratory infections, and sexually transmitted infections, as well as oncology and maternal health. Sansure also provides integrated laboratory automation systems, including nucleic acid extractors and real-time PCR instruments, designed to streamline clinical workflows and improve diagnostic efficiency for healthcare providers and research institutions globally.

Recent filings

Filing Released Lang Actions
圣湘生物科技股份有限公司2026年第二次临时股东会会议资料
AGM Information Classification · 95% confidence The document is titled as meeting materials for the "2026 Second Extraordinary General Meeting of Shareholders" of 圣湘生物科技股份有限公司. It includes detailed meeting instructions, agenda, and a specific proposal regarding the registration and issuance of medium-term notes (中期票据). The content is focused on the meeting process, voting procedures, and the proposal to authorize the board to handle the issuance of debt instruments. This is clearly a set of materials prepared for a shareholders' meeting, not the meeting minutes or voting results themselves. It is not a full financial report, audit report, or earnings release. It is not a proxy solicitation or voting results announcement. The document is a presentation of information and proposals to shareholders for the meeting. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual or Extraordinary General Meeting.
2026-04-15 Chinese
圣湘生物科技股份有限公司关于拟注册和发行中期票据的公告
Capital/Financing Update Classification · 100% confidence The document is an announcement from 圣湘生物科技股份有限公司 regarding the proposed registration and issuance of medium-term notes (中期票据). It details the basic information about the issuance, authorization matters, impact on the company, approval procedures, and risk warnings. The document is a formal announcement about a financing activity, specifically the registration and issuance of debt instruments to raise capital. It does not contain financial statements or detailed financial performance data, nor is it a transcript, report, or voting result. The content fits the category of Capital/Financing Update (CAP), as it provides updates on the company's fundraising and financing activities.
2026-04-07 Chinese
圣湘生物科技股份有限公司2026年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the company's first extraordinary general meeting of shareholders in 2026. It details the meeting date, attendance, voting results on a specific proposal, and legal witness statements confirming the legality and validity of the meeting and resolutions. There is no financial data or report content, but rather an official announcement of shareholder meeting decisions and voting outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting results, not a full report or presentation.
2026-03-31 Chinese
湖南启元律师事务关于圣湘生物科技股份有限公司2026年第一次临时股东会法律意见书
Regulatory Filings
2026-03-31 Chinese
圣湘生物科技股份有限公司2026年第一次临时股东会会议资料
AGM Information Classification · 95% confidence The document is titled as the "2026 First Extraordinary General Meeting (EGM) Meeting Materials" of 圣湘生物科技股份有限公司. It contains detailed meeting instructions, agenda, and a specific investment proposal to be voted on by shareholders. The content is focused on the materials prepared for the shareholders' meeting, including procedural rules, voting instructions, and the investment proposal details. There are no financial statements or quarterly/yearly financial results presented, nor is this a transcript or announcement of results. The document is not a report publication announcement but the actual meeting materials. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during a general meeting (in this case, an extraordinary general meeting).
2026-03-23 Chinese
圣湘生物科技股份有限公司关于召开2026年第一次临时股东会的通知
Regulatory Filings Classification · 95% confidence The document is a notice about convening the 2026 first extraordinary general meeting of shareholders (临时股东会) for 圣湘生物科技股份有限公司. It details the meeting date, voting methods, agenda items, registration procedures, and includes an authorization proxy form for voting. There is no financial data, earnings, audit information, or report content. The document is an announcement informing shareholders about the meeting and voting process, not the results or the meeting materials themselves. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting procedures rather than the solicitation of votes or proxy materials, it is best classified as a Regulatory Filing (RNS) as a fallback for general regulatory announcements and notices that do not fit other categories. The document length is under 5,000 characters and is a formal announcement, not a report or transcript.
2026-03-15 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.